Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126588141 | 12658814 | 1 | I | 20160803 | 20160817 | 20160817 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002452 | VALIDUS | TAHIR A., MCLAUGHLIN K., KLINE G.. SEVERE HYPERKALEMIA FOLLOWING ADRENALECTOMY FOR ALDOSTERONOMA: PREDICTION, PATHOGENESIS AND APPROACH TO CLINICAL MANAGEMENT-A CASE SERIES. BMC ENDOCR. DISORD.. 2016;16 (1) | 51.00 | YR | F | Y | 0.00000 | 20160817 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126588141 | 12658814 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, QD | 16273 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126588141 | 12658814 | 1 | Hyperaldosteronism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126588141 | 12658814 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126588141 | 12658814 | Blood creatine increased | |
126588141 | 12658814 | Hyperkalaemia | |
126588141 | 12658814 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |